Novo Nordisk Shares Face Mounting Pressure as Analyst Warns of Further Declines
01.12.2025 - 13:15:05 | boerse-global.de
A leading financial institution has issued a stark warning for investors in Novo Nordisk, suggesting the Danish pharmaceutical giant’s stock may continue its precipitous fall. Despite a year-to-date loss of approximately 50% in market capitalization, Jefferies analysts believe the bottom has not yet been reached.
In a move that dampened market sentiment, Jefferies resumed coverage of Novo Nordisk with a stark “Underperform” rating. Analyst Michael Leuchten set a price target of 270 Danish Krone (DKK), implying a potential further decline of about 14% from current trading levels. The firm’s analysis points to two core concerns: the continued absence of a valuation floor despite the year’s severe losses and looming structural Read more...
So schätzen die Börsenprofis Novo Aktien ein!
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
Für. Immer. Kostenlos.
DK0062498333 | NOVO | boerse | 68402889 |
